PreprintCited by 22Ubiquitin and proteasome pathwaysProtein Degradation and InhibitorsMultiple Myeloma Research and Treatments

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma

Open access

Preprint — published as 10.1016/j.molcel.2025.05.030 · Paper page

Abstract

Summary: The midnolin-proteasome pathway degrades many nuclear proteins without ubiquitination, but how it operates mechanistically remains unclear. Here, we present structures of the midnolin-proteasome complex, revealing how established proteasomal components are repurposed to enable a unique form of proteolysis. While the proteasomal subunit PSMD2/Rpn1 binds to ubiquitinated or ubiquitin-like proteins, we discover that it also interacts with the midnolin nuclear localization sequence, elucidating how midnolin’s activity is confined to the nucleus. Likewise, PSMD14/Rpn11, an enzyme that normally cleaves ubiquitin chains, surprisingly functions non-enzymatically as a receptor for the midnolin ubiquitin-like (Ubl) domain, positioning the substrate-binding Catch domain directly above the proteasomal entry site to guide substrates into the proteasome. Moreover, we demonstrate that midnolin downregulation is critical for the survival of myeloma cells by promoting the expression of its transcription factor substrate IRF4. Our findings uncover the mechanisms underlying the midnolin-proteasome pathway and midnolin downregulation as a driver of multiple myeloma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.02.22.639686

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 60

  1. 10.1038/nm.3739 · DOI
  2. 10.1042/BST20191094 · DOI
  3. 10.1146/annurev-biochem-062917-011931 · DOI
  4. 10.1016/S0092-8674(00)80843-0 · DOI
  5. 10.1126/science.adh5021 · DOI
  6. 10.1016/j.devcel.2016.05.013 · DOI
  7. 10.1016/j.neuron.2018.10.013 · DOI · Paper page
  8. 10.1161/CIRCRESAHA.111.253377 · DOI
  9. 10.3390/cells8111373 · DOI
  10. 10.1038/s41580-021-00341-1 · DOI
  11. 10.1038/ni1357 · DOI
  12. 10.1038/nature07064 · DOI · Paper page
  13. 10.1152/ajpgi.00011.2023 · DOI
  14. 10.1038/ncb845 · DOI
  15. 10.1074/jbc.M404020200 · DOI
  16. 10.1038/nature06926 · DOI
  17. 10.1126/science.aad9421 · DOI
  18. 10.1016/j.molcel.2008.03.004 · DOI
  19. 10.1126/science.1075898 · DOI
  20. 10.1038/nature01071 · DOI
  21. 10.1038/nsmb.2771 · DOI
  22. 10.1038/nsmb.2616 · DOI · Paper page
  23. 10.1016/j.molcel.2023.07.023 · DOI
  24. 10.1126/science.aav0725 · DOI
  25. 10.1038/s41586-018-0736-4 · DOI · Paper page
  26. 10.1016/j.jbc.2021.101052 · DOI
  27. 10.1016/j.str.2016.05.018 · DOI
  28. 10.1038/s41586-022-04671-8 · DOI
  29. 10.1101/2021.10.04.463034 · DOI · Paper page
  30. 10.1126/science.abi6983 · DOI · Paper page
  31. 10.1038/20367 · DOI
  32. 10.1083/jcb.131.6.1699 · DOI
  33. 10.1016/0092-8674(95)90331-3 · DOI
  34. 10.1074/jbc.M209037200 · DOI
  35. 10.1038/s41586-024-07487-w · DOI · Paper page
  36. 10.1126/science.1160489 · DOI · Paper page
  37. 10.1126/science.1160462 · DOI
  38. 10.1038/s41559-020-01327-6 · DOI
  39. 10.1182/blood-2014-11-568881 · DOI
  40. 10.1038/s43018-023-00550-x · DOI
  41. 10.1016/j.cell.2017.06.010 · DOI · Paper page
  42. 10.1182/blood.2022016892 · DOI
  43. 10.1093/nar/gkaa1100 · DOI · Paper page
  44. 10.15252/embr.201947910 · DOI
  45. 10.1084/jem.20232132 · DOI
  46. 10.1038/s41572-024-00529-7 · DOI
  47. 10.1016/j.molcel.2022.12.013 · DOI
  48. 10.1016/j.jsb.2005.07.007 · DOI
  49. 10.1038/nmeth.4169 · DOI · Paper page
  50. 10.1107/S2059798319011471 · DOI · Paper page
  51. 10.1107/S0907444910007493 · DOI · Paper page
  52. 10.1107/S0907444909047337 · DOI · Paper page
  53. 10.1107/S0021889807021206 · DOI · Paper page
  54. 10.1038/nmeth.1896 · DOI · Paper page
  55. 10.1002/pro.4792 · DOI
  56. 10.1038/s41586-024-07215-4 · DOI · Paper page
  57. 10.1021/bi061994u · DOI · Paper page
  58. 10.1073/pnas.1902931116 · DOI
  59. 10.1021/acs.jproteome.7b00913 · DOI
  60. 10.1002/pmic.201200439 · DOI · Paper page

Metadata

Authors
Nardone, C., Gao, J., Seo, H.-S., Mintseris, J., Ort, L., Yip, M. C. J., Negasi, M., Besschetnova, A. K., Kamitaki, N., Gygi, S. P., Dhe-Paganon, S., Munshi, N., Fulciniti, M., Greenberg, M. E., Shao, S., Elledge, S. J., & Gu, X.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • Dana-Farber Cancer Institute (US)
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
  • VA Boston Healthcare System (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Shao, Sichen
  • Elledge, Stephen J.
  • Gu, Xin
Venue
Molecular Cell
Publisher
openRxiv
Published
2025-02-23
Volume
85
Issue
13
Pages
2597-2609.e11
ISSN
1097-2765 (ISSN-L)
OpenAlex
W4411370036
Cited by
22
References
1
Citations by year
2026: 15 · 2025: 7
FWCI
6.61
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed Central (submittedVersion)
Funders
  • National Science Foundation
  • David and Lucile Packard Foundation
  • Howard Hughes Medical Institute
  • American Heart Association (287375208)
  • Damon Runyon Cancer Research Foundation (DRG-2469-22)
  • National Institutes of Health (R01073277, GM97645, CA155258-10)
  • National Institute on Aging (R01AG073277, R01AG011085)
  • National Heart, Lung, and Blood Institute (R01HL177823)
  • National Human Genome Research Institute (T32HG002295)
  • National Cancer Institute (P01CA155258)
  • National Institute of Neurological Disorders and Stroke (R01NS115965)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
Keywords
proteasome, multiple myeloma, ubiquitin-like proteins, nuclear localization signal, transcription factor degradation, proteasome structure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review